Metabolic studies using radioiodine-labeled third component of complement (C3) and the glycine-rich β glycoprotein (GBG), a major component of the C3b-feedback pathway, were undertaken in normal subjects, in 22 patients with evidence of complement activation, and in 11 patients with various renal diseases without evidence of complement activation. In seven normal subjects GBG was found to be a rapidly metabolized protein with catabolic rates ranging from 1.7% to 2.2% of the plasma pool/h, synthesis rates from 0.14 to 0.21 mg/kg per h. and extravascular/intravascular distribution ratios from 0.81 to 1.31. In patients with reduced plasma C3, both increased C3 fractional catabolic rates and reduced C3 synthesis rates were observed, and in some patients there was evidence of increased extravascular distribution of the protein. GBG catabolism was usually increased when there was evidence of C3 activation, presumably reflecting activation of the C3b-feedback; but GBG turnover was normal or only slightly accelerated in some patients with accelerated C3 catabolism and profound hypocomplementemia, suggesting that reduced C3 synthesis had limited activation of the C3b-feedback.
J. A. Charlesworth, D. Gwyn Williams, E. Sherington, P. J. Lachmann, D. K. Peters
Title and authors | Publication | Year |
---|---|---|
Generation of complement protein C3 deficient pigs by CRISPR/Cas9-mediated gene targeting
W Zhang, G Wang, Y Wang, Y Jin, L Zhao, Q Xiong, L Zhang, L Mou, R Li, H Yang, Y Dai |
Scientific Reports | 2017 |
The Clinical Chemistry of Laboratory Animals
DM Kurtz, GS Travlos |
The Clinical Chemistry of Laboratory Animals | 2017 |
Self-nonself discrimination by the complement system
S Meri |
FEBS Letters | 2016 |
A Quantitative Lateral Flow Assay to Detect Complement Activation in Blood
EC Schramm, NR Staten, Z Zhang, SS Bruce, C Kellner, JP Atkinson, VC Kyttaris, GC Tsokos, M Petri, ES Connolly, PK Olson |
Analytical Biochemistry | 2015 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Complement Activation During Liver Transplantation-Special Emphasis on Patients With Atypical Hemolytic Uremic Syndrome : Complement Activation in Liver Transplantation
AR Koskinen, E Tukiainen, J Arola, A Nordin, HK Höckerstedt, B Nilsson, H Isoniemi, TS Jokiranta |
American Journal of Transplantation | 2011 |
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice
Kirsten L. Rose Danielle Paixao-Cavalcante Jennifer Fish Anthony P. Manderson Talat Malik Anne E. Bygrave Tao Lin Steven H. Sacks Mark J. Walport H. Terence Cook Marina Botto Matthew C. Pickering |
Journal of Clinical Investigation | 2008 |
Novartis Foundation Symposia
EJ Campbell |
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction | 2008 |
A hemolytic method for the measurement of nephritic factor
CD West |
Journal of Immunological Methods | 2008 |
Systemic Lupus Erythematosus
M Petri |
JCR: Journal of Clinical Rheumatology | 2006 |
The role of biomarkers in the assessment of lupus
JT Merrill, JP Buyon |
Best Practice & Research Clinical Rheumatology | 2005 |
Clinical Features and Metabolic and Autoimmune Derangements in Acquired Partial Lipodystrophy
A Misra, A Peethambaram, A Garg |
Medicine | 2004 |
Complement in renal disease
JA Charlesworth, PW Peake, BA Pussell, JH Erlich |
Nephrology | 2001 |
Vascular Manifestations of Systemic Autoimmune Diseases
C Kallenberg, JC Tervaert |
Vascular Manifestations of Systemic Autoimmune Diseases | 2001 |
Molecular and Cellular Basis of Inflammation
CN Serhan, PA Ward |
1999 | |
INFECTION IN SYSTEMIC LUPUS ERYTHEMATOSUS
M Petri |
Rheumatic Disease Clinics of North America | 1998 |
Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): clinical findings and the coincidence of C3 NeF type II with anti-C1q autoantibodies
L Skattum, U Martensson, AG Sjöholm |
Journal of Internal Medicine | 1997 |
Paramesangial glomerular deposits in membranoproliferative glomerulonephritis type II correlate with hypocomplementemia
CD West, AJ McAdams |
American Journal of Kidney Diseases | 1995 |
Clinical utility of complement assessment
AE Ahmed, JB Peter |
Clinical and diagnostic laboratory immunology | 1995 |
Complement activation by cellulosic dialysis membranes
A Innes, AM Farrell, RP Burden, AG Morgan, RJ Powell |
Journal of clinical pathology | 1994 |
Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus
E Röther, B Lang, R Coldewey, K Hartung, HH Peter |
Clinical Rheumatology | 1993 |
Molecular analysis of C3 allotypes in patients with nephritic factor
JE Finn, PW Mathieson |
Clinical & Experimental Immunology | 1993 |
Molecular analysis of C3 allotypes in patients with nephritic factor.
Finn JE, Mathieson PW |
Clinical & Experimental Immunology | 1993 |
Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritis factor and persistently low complement C3 and C5
SA Hulton, RA Risdon, MJ Dillon |
Pediatric Nephrology | 1992 |
Assessment of complement activation in vivo
M Oppermann, U Höpken, O Götze |
Immunopharmacology | 1992 |
The Complement System
A Agostoni, M Cicardi, M Gardinali, L Bergamaschini |
International journal of immunopathology and pharmacology | 1992 |
Idiopathic membranoproliferative glomerulonephritis in childhood
CD West |
Pediatric Nephrology | 1992 |
C3 Activation Products, C3 Containing Immune Complexes, the Terminal Complement Complex and Native C9 in Patients with Rheumatoid Arthritis
Ü Ölmez, P Garred, TE Mollnes, M Harboe, HB Berntzen, E Munthe |
Scandinavian Journal of Rheumatology | 1991 |
INHERITED DEFICIENCIES OF COMPLEMENT PROTEINS : with special reference to congenital deficiency of the regulatory protein factor I
JE RASMUSSEN |
APMIS | 1991 |
INHERITED DEFICIENCIES OF COMPLEMENT PROTEINS: with special reference to congenital deficiency of the regulatory protein factor I
JE RASMUSSEN |
APMIS | 1991 |
Relative Value of Serum C3 and C4 Levels in Predicting Relapse in Systemic Lupus Erythematosus
CD West |
American Journal of Kidney Diseases | 1991 |
Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease
ET Littleton, L Bevis, LJ Hansen, M Peakman, AP Mowat, G Mieli-Vergani, D Vergani |
Journal of clinical pathology | 1991 |
Immunology of Renal Disease
CD Pusey |
1991 | |
Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis
PN Hawkins, R Wootton, MB Pepys |
Journal of Clinical Investigation | 1990 |
The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus
N Negoro, M Okamura, T Takeda, S Koda, K Amatsu, T Inoue, JG Curd, Y Kanayama |
Arthritis & Rheumatism | 1989 |
Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity
LD Kerr, BR Adelsberg, P Schulman, H Spiera |
Arthritis & Rheumatism | 1989 |
Activation of the complement system in systemic sclerosis. Relationship to clinical severity
G Senaldi, S Lupoli, D Vergani, CM Black |
Arthritis & Rheumatism | 1989 |
THE METABOLISM OF C3 AND C4 IN PATIENTS WITH IMMUNE COMPLEXES AND NORMAL COMPLEMENT LEVELS
JA Charlesworth, PW Peake, J Golding, BA Pussell, V Timmermans, I Wicks, D Wakefield |
Australian and New Zealand Journal of Medicine | 1989 |
Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?
M Peakman, G Senaldi, D Vergani |
Journal of clinical pathology | 1989 |
Differences in the metabolism of C4 isotypes in patients with complement activation
PW Peake, BA Pussell, JA Charlesworth, L Gavrilovic, V Timmermans |
Clinical & Experimental Immunology | 1989 |
A new method for the estimation of C3d
SS Asghar, B Schraag, AH Backhaus, I Zorn, GT Venneker, AJ Hannema |
Journal of Immunological Methods | 1989 |
Serum terminal complement component levels in hypocomplementemic glomerulonephritides
CW Clardy, J Forristal, CF Strife, CD West |
Clinical Immunology and Immunopathology | 1989 |
Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B
M Oppermann, M Haubitz, E Quentin, O Götze |
Klinische Wochenschrift | 1988 |
Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis
P Hopkins, HM Belmont, J Buyon, M Philips, G Weissmann, SB Abramson |
Arthritis & Rheumatism | 1988 |
Hereditary C3 hypocomplementemia in the rabbit
M Komatsu, K Yamamoto, Y Nakano, M Nakazawa, A Ozawa, H Mikami, M Tomita, S Migita |
Immunology | 1988 |
The complement system in Type 1 (insulin-dependent) diabetes
JA Charlesworth, V Timmermans, J Golding, LV Campbell, PW Peake, BA Pussell, D Wakefield, N Howard |
Diabetologia | 1987 |
Quantification of C3d in biological fluids by an enzyme-linked immunosorbent assay
M Peakman, A Lobo-Yeo, G Senaldi, M Nilsson, DE Tee, D Vergani |
Journal of Immunological Methods | 1987 |
Quantiation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation
FB Waldo, CD West |
Clinical Immunology and Immunopathology | 1987 |
Hypocomplementemia with low Cls-Cl inhibitor complex in systemic lupus erythematosus
MD Lockshin, T Qamar, P Redecha, PC Harpel |
Arthritis & Rheumatism | 1986 |
Direct quantitation of activated C3 in human plasma with monoclonal anti-iC3b-C3d-neoantigen
Y Kanayama, Y Kurata, R McMillan, JD Tamerius, N Negoro, JG Curd |
Journal of Immunological Methods | 1986 |
Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex
TE Mollnes, T Lea, OJ Mellbye, J Pahle, Ø Grand, M Harboe |
Arthritis & Rheumatism | 1986 |
Membranoproliferative Glomerulonephritis, Type II and Partial Lipodystrophy in an Adult
J Pollock, B Wood, JP Kelly |
American Journal of Kidney Diseases | 1986 |
Complement in the Pathophysiology and Diagnosis of Human Diseases
AP Dalmasso |
Critical Reviews in Clinical Laboratory Sciences | 1986 |
Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course
AJ Swaak, A van Rooyen, C Vogelaar, M Pillay, E Hack |
Rheumatology International | 1986 |
Human fibronectin metabolism
BA Pussell, PW Peake, MA Brown, JA Charlesworth |
Journal of Clinical Investigation | 1985 |
GENETICALLY DETERMINED LOW C4: A PREDISPOSING FACTOR TO AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
D Vergani, VF Larcher, ET Davies, L Wells, BA Nasaruddin, G Mieli-Vergani, AP Mowat |
The Lancet | 1985 |
Dual Cutaneous Reactions to Anti-Human IgE; No Change in Plasma Level of the Split Product Complement C3d or Effect of Heparin
R Gröonneberg |
Allergy | 1985 |
Complement levels and C3 breakdown products in open-heart surgery: association of C3 conversion with the postpericardiotomy syndrome
S Meri, K Verkkala, A Miettinen, V Valtonen, E Linder |
Clinical & Experimental Immunology | 1985 |
Immunology of Rheumatic Diseases
S Gupta, N Talal |
1985 | |
Complement Activation in Renal Disease
CD West |
Renal Failure | 1984 |
C3 metabolism in acute glomerulonephritis: Implications for sites of complement activation
ZH Endre, BA Pussell, JA Charlesworth, HM Coovadia, YK Seedat |
Kidney International | 1984 |
Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d
I Brandslund, B Teisner, PH Petersen, SE Svehag |
Scandinavian Journal of Clinical & Laboratory Investigation | 1984 |
CIRCULATING IMMUNE COMPLEXES AND COMPLEMENT BREAKDOWN PRODUCT C3d IN GLOMERULONEPHRITIS AND KIDNEY TRANSPLANTATION
J Sølling |
Acta Pathologica Microbiologica Scandinavica Series C: Immunology | 1984 |
C3 NEPHRITIC FACTOR IN A PATIENT WITH RECURRENT NEISSERIA MENINGITIDIS INFECTIONS
B Teisner, P Elling, SE Svehag, L Poulsen, LU Lamm, A Sjöholm |
Acta Pathologica Microbiologica Scandinavica Series C: Immunology | 1984 |
Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus
D Adu, DG Williams |
Clinical & Experimental Immunology | 1984 |
Plasma C3d/C3 quotient as a parameter for in vivo complement activation
W Nürnberger, S Bhakdi |
Journal of Immunological Methods | 1984 |
The third complement factor (C3) and its in vivo cleavage products: Interaction with lectins and precipitation with polyethylene glycol
B Teisner, J Hau, SE Svehag, I Brandslund, TC Bøg-Hansen |
Journal of Immunological Methods | 1984 |
A simple method for quantitative measurement of C3d in human plasma
S Bhakdi, M Roth, W Nürnberger |
Journal of Immunological Methods | 1984 |
Cutaneous leishmaniasis: immune complex formation and necrosis in the acute phase
MJ Ridley, DS Ridley |
British Journal of Experimental Pathology | 1984 |
Pathophysiology of Plasma Protein Metabolism
G Mariani |
1984 | |
Breakdown Product of Factor B as an Index of Complement Activation in Lepromatous Leprosy and Its Relation with Bacillary Load
K Saha, V Sharma, AK Chakrabarty, VN Sehgal |
Scandinavian Journal of Immunology | 1983 |
Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor
RA Thompson, PL Yap, RB Brettle, RE Dunmow, H Chapel |
Clinical & Experimental Immunology | 1983 |
A single step immunoelectrophoresis method for the quantitation of complement C3c in biological fluids
A Berkowicz, J Rosenkvist, H Sørensen |
Journal of Immunological Methods | 1983 |
The in vivo metabolism of C3 in human glomerulonephritis and after renal transplantation
L Brinch, I Aakesson, P Teisberg, E Enger |
Scandinavian Journal of Clinical & Laboratory Investigation | 1983 |
Clinical application of a new nephelometric technique to measure complement activation
D Vergani, L Bevis, BA Nasaruddin, G Mieli-Vergani, DE Tee |
Journal of clinical pathology | 1983 |
Complement Deficiency and Disease
JA Charlesworth, BA Pussell |
Australian and New Zealand Journal of Medicine | 1982 |
Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity
RK Mallya, D Vergani, DE Tee, L Bevis, FC de Beer, H Berry, ED Hamilton, BE Mace, MB Pepys |
Clinical & Experimental Immunology | 1982 |
Influence of time, temperature and coagulation on the measurement of C3, C3 split products and C4
MJ Sinosich, B Teisner, I Brandslund, M Fisher, JG Grudzinskas |
Journal of Immunological Methods | 1982 |
Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis
BE Bourke, IK Moss, RN Maini |
Journal of Immunological Methods | 1982 |
Circulating C3, C4, and C3 Split Products (C3c and C3d) During Normal Pregnancy*
B Teisner, J Hau, M Tucker, J Lahood, JG Grudzinskas |
American Journal of Reproductive Immunology | 1982 |
Loculated Pleural Empyema: Identification of Complement Breakdown Products in Contiguous Sterile Pleural Fluid
PD Lew, LH Perrin, FA Waldvogel, PH Lambert |
Scandinavian Journal of Infectious Diseases | 1982 |
Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes
AJ Swaak, A Hannema, C Vogelaar, FA Boom, L van Es, R van Aalst, LW van Eps |
Rheumatology International | 1982 |
The in-vivo metabolism of C3 in ankylosing spondylitis
L Brinch, O Vinje, P Teisberg, OJ Mellbye, I Aakesson |
Annals of the rheumatic diseases | 1982 |
Molecular aspects of complement activation
K Whaley, A Ferguson |
Molecular Aspects of Medicine | 1981 |
Hypocomplementaemia due to a genetic deficiency of beta 1H globulin
RA Thompson, MH Winterborn |
Clinical & Experimental Immunology | 1981 |
Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma
I Brandslund, HC Siersted, SE Svehag, B Teisner |
Journal of Immunological Methods | 1981 |
Immunological Aspects of Rheumatology
WC Dick |
1981 | |
Clinical Significance of Serum Complement Levels in Post-streptococcal Acute Glomerulonephritis
Y Koitabashi, T Maruyama, T Baba |
Pediatrics International | 1980 |
Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins
MT Aguado, LH Perrin, R Ramirez, PA Miescher, PH Lambert |
Clinical & Experimental Immunology | 1980 |
Change in Serum Properdin Factor B Phenotype Following Human Orthoptic Liver Transplantation
G Hauptmann, MM Tongio, J Klein, S Mayer, J Cinqualbre, B Jeanblanc, R Kieny |
Immunobiology | 1980 |
The Metabolism of C3 in Adult Coeliac Disease
L Brinch, P Teisberg, O Fausa, I ÅKesson |
Scandinavian Journal of Gastroenterology | 1980 |
Complement activation in pneumonia
U Nydegger, JJ Farquet, R Zubler, PH Lambert, PA Miescher |
Medical Microbiology and Immunology | 1979 |
Circulating immune complexes and C3d in human parasitosis
PJ Verroust, C Adam, MD Smith, D Richard-Lenoble, O Kourilsky, LJ Morel-Maroger |
Kidney International | 1979 |
Complement activation profiles in disease
DL Brown |
Journal of clinical pathology. Supplement (Royal College of Pathologists) | 1979 |
Complement activation in asymptomatic patients with sickle cell anaemia
WA Wilson, EJ Thomas, JG Sissons |
Clinical & Experimental Immunology | 1979 |
Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus
K Whaley, PH Schur, S Ruddy |
Clinical & Experimental Immunology | 1979 |
Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis
K Whaley, D Ward, S Ruddy |
Clinical & Experimental Immunology | 1979 |
Experimental immune glomerulonephritis induced in the rabbit with streptococcal vaccine
B Bellon, J Kuhn, K Ayed, JF Girard, P Druet |
Clinical & Experimental Immunology | 1979 |
Metabolism of human beta 1H: studies in man and experimental animals
JA Charlesworth, DM Scott, BA Pussell, DK Peters |
Clinical & Experimental Immunology | 1979 |
Metabolic studies of C3 in man
L Brinch, P Teisberg, I Aakesson |
Journal of Immunological Methods | 1979 |
Identification of nephritic factor as an immunoglobulin
DG Williams, A Bartlett, P Duffus |
Clinical & Experimental Immunology | 1978 |
Hypocomplementemia in a newborn infant caused by placental transfer of C3 nephritic factor
Y Kim, Y Shvil, AF Michael |
The Journal of Pediatrics | 1978 |
Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN)
M Levy, MC Gubler, M Sich, A Beziau, R Habib |
Clinical Immunology and Immunopathology | 1978 |
Complement in cystic fibrosis
M Gtz, G Lubec |
European Journal of Pediatrics | 1978 |
Immune Complexes and the Rheumatic Diseases
PH Lambert, P Casali |
Clinics in rheumatic diseases | 1978 |
Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation
JG Sissons, J Liebowitch, N Amos, DK Peters |
Journal of Clinical Investigation | 1977 |
Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity
UE Nydegger, RH Zubler, R Gabay, G Joliat, CH Karagevrekis, PH Lambert, PA Miescher |
Journal of Clinical Investigation | 1977 |
INHERITED DEFICIENCIES OF COMPLEMENT IN MAN
TL Ray, KD Wuepper |
International Journal of Dermatology | 1977 |
Serum immune complexes in membranoproliferative and other glomerulonephritides
YM Ooi, EH Vallota, CD West |
Kidney International | 1977 |
The in Vivo Metabolism of the Third Component of Complement in Systemic Lupus Erythematosus
LD Petz, R Powers, JR Fries, NR Cooper, HR Holman |
Arthritis & Rheumatism | 1977 |
Pathways of complement activation in chronic discoid lupus
MA Schrager, NF Rothfield |
Arthritis & Rheumatism | 1977 |
The Nail Patella Syndrome-A Report of a Family
BA Pussell, JA Charlesworth, GJ Macdonald, WC Baker |
Australian and New Zealand Journal of Medicine | 1977 |
The Complement System in Infectious Mononucleosis
JA Charlesworth, BA Pussell, LP Roy, S Lawrence, MR Robertson |
Australian and New Zealand Journal of Medicine | 1977 |
COMPLEMENT ACTIVATION IN MIGRAINE
GD Lord, TW Duckworth, JA Charlesworth |
The Lancet | 1977 |
Correlations between serum factor B and C3b inactivator levels in normal subjects and in patients with infections, nephrosis and hypocomplementaemic glomerulonephritis
J Forristal, K Iitaka, EH Vallota, CD West |
Clinical & Experimental Immunology | 1977 |
Acute hepatitis: significance of changes in complement components
JA Charlesworth, S Lawrence, PA Worsdall, LP Roy, CR Boughton |
Clinical & Experimental Immunology | 1977 |
Normal complement in early poststreptococcal glomerulonephritis
RH McLean, MA Schrager, NF Rothfield, MA Berman |
British medical journal | 1977 |
Genetic deficiency of the second component of complement (C2) associated with systemic lupus erythematosus
RI Rynes, RE Urizar, RJ Pickering |
The American Journal of Medicine | 1977 |
Disorders of the complement system in lipodystrophy
MM Ipp, JO Minta, EW Gelfand |
Clinical Immunology and Immunopathology | 1977 |
Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus
MA Schrager, NF Rothfield |
Journal of Clinical Investigation | 1976 |
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase
K Whaley, PH Schur, S Ruddy |
Journal of Clinical Investigation | 1976 |
Pathogenesis and approaches to therapy of membranoproliferative glomerulonephritis
CD West |
Kidney International | 1976 |
Nephritic factor: Description of a new quantitative assay and findings in glomerulonephritis
WA Border, CB Wilson, O Götze |
Kidney International | 1976 |
Measles infection. Involvement of the complement system
JA Charlesworth, BA Pussell, LP Roy, MR Robertson, J Beveridge |
Clinical & Experimental Immunology | 1976 |
C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus
JH Wild, NJ Zvaifler, HJ Müller-Eberhard, CB Wilson |
Clinical & Experimental Immunology | 1976 |
Activation of the alternative complement pathway in systemic lupus erythematosus
MR Wilson, CM Arroyave, RM Nakamura, JH Vaughan, EM Tan |
Clinical & Experimental Immunology | 1976 |
The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro
N Amos, JG Sissons, JF Girard, PJ Lachmann, DK Peters |
Clinical & Experimental Immunology | 1976 |
Detection of complement activation by counterimmunoelectrophoresis (CIE)
CM Arroyave, EM Tan |
Journal of Immunological Methods | 1976 |
The Complement Abnormalities of Lipodystrophy
JG Sissons, RJ West, J Fallows, DG Williams, BJ Boucher, N Amos, DK Peters |
New England Journal of Medicine | 1976 |
Complement and the Clinician
DG Palmer |
Australian and New Zealand Journal of Medicine | 1976 |
Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis
LH Perrin, PH Lambert, PA Miescher |
Journal of Clinical Investigation | 1975 |
Metabolism of properdin in normal subjects and patients with renal disease
JB Ziegler, FS Rosen, CA Alper, W Grupe, IH Lepow |
Journal of Clinical Investigation | 1975 |
Studies in vivo of cobra factor and murine C3
MB Pepys |
Immunology | 1975 |
Effects on serum complement of normal and pre-eclamptic pregnancy and of oral contraceptives
RS Tedder, M Nelson, V Eisen |
British Journal of Experimental Pathology | 1975 |
SIGNIFICANCE OF COMPLEMENT-POSITIVE COOMBS TEST IN PATIENTS WITH GLOMERULAR DISEASE
O Kourilsky, JP Lucas, C Poyau-Lemaux, G Neuilly, G Richet |
The Lancet | 1974 |
SKIN LESIONS, ANGIO-ŒDEMA, AND HYPOCOMPLEMENTÆMIA
JG Sissons, DK Peters, DG Williams, JM Boulton-Jones, HJ Goldsmith |
The Lancet | 1974 |
Studies of serum complement in the hypocomplementaemic nephritides
DG Williams, DK Peters, J Fallows, A Petrie, O Kourilsky, L Morel-Maroger, JS Cameron |
Clinical & Experimental Immunology | 1974 |